Ixico PLC on Monday said Bram Goorden will succeed the company’s outgoing head, bringing with him two decades of industry-specific knowledge.
The London-based precision analytics and medical imaging services provider announced that Bram Goorden will join the company as chief executive officer on August 19, replacing retiring Giulio Cerroni.
Chair Mark Warne said: ‘I am delighted to welcome Bram to the board as our CEO. Bram has significant track record in the commercial application of AI precision medicine solutions that is complemented by technical knowledge within neurodegenerative diseases. As IXICO looks to return to growth, Bram’s experiences provide excellent credentials to ensure IXICO also realises shareholder value.’
Goorden has more than two decades of experience working in biopharma and precision medicines, having served in senior management roles at Eli Lilly & Co and UCB Pharma SA.
More recently, Goorden was chief operating officer at Eagle Genomics Ltd where he expanded the company’s US footprint and delivered key industry alliances.
Ixico shares were up 7.1% to 7.50 pence each in London on Monday afternoon.
Copyright 2024 Alliance News Ltd. All Rights Reserved.
